Evidence map›Paper›PMID 36371744›Full record

ArticleArchives of microbiology2022

Lignocellulose-degrading fungi newly isolated from central Morocco are potent biocatalysts for olive pomace valorization.

Soukaina Arif, Hasna Nait M'Barek, Saïd Oulghazi, Kris Audenaert, Hassan Hajjaj

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Soukaina ArifLaboratory of Biotechnology and Bioresources Valorization, Faculty of Sciences, Moulay Ismail University of Meknès, BP 11201, Zitoune, Meknes, Morocco.
Hasna Nait M'BarekCentraleSupélec, SFR Condorcet FR, CNRS 3417, Paris-Saclay University, European Center of Biotechnology and Bioeconomy (CEBB) - LGPM, 3 rue des Rouges Terres, 51110, Pomacle, France.
Saïd OulghaziInstitute for Integrative Biology of the Cell (I2BC), CEA CNRS Paris-Saclay University, 91190, Gîf-sur-Yvette, France.
Kris AudenaertLaboratory of Applied Mycology and Phenomics, Department of Plants and Crops, Faculty of Bioscience Engineering, Ghent University, 9000, Ghent, Belgium.
Hassan HajjajLaboratory of Biotechnology and Bioresources Valorization, Faculty of Sciences, Moulay Ismail University of Meknès, BP 11201, Zitoune, Meknes, Morocco. h.hajjaj@umi.ac.ma.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The investigation of lignocellulolytic catalysts is an important feature to face the challenges of lignocellulosic biomass valorization. In central Morocco, fungi were isolated from decaying wood, soil, olive crushing by-products and their compost. One hundred fifty-five isolates were submitted to a selective screening, which served to distinguish 83% of lignocellulolytic isolates. Then, a collection of 56 fungi was subjected to morphological and molecular identification with the ITS5 and ITS4 primers. This approach showed that 45% of the fungal population belonged to the genus Penicillium, followed by Aspergillus 14%, and Fusarium 11%. Alternaria, Trichoderma, Paecilomyces, Cladosporium, Trichocladium, Circinella, and Doratomyces genera are founded with a minority occurrence. Finally, validation of the enzymatic profile was done for 20 isolates, by testing their enzymatic performance on a liquid medium in the presence of cellulose, lignin, and olive pomace. The maximum protein production of 788 µg ml

Indexed as

OleaPenicilliumTrichodermaAlternariaFungiLigninMoroccoLigninlignocelluloseBiomass valorizationBiotechnologyFilamentous fungiHigh-value moleculesLignocellulolytic activities

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.